Final test results confirm an experimental Ebola vaccine is highly effective, a major milestone that could help prevent the spread of outbreaks like the one that killed thousands in West Africa. Scientists have struggled to develop an Ebola vaccin ...
For the first time, it has been shown that many mutations in tumors--20 percent—are immunogenic, or able to rouse armies of T cells, post-vaccine. Also for the first time, it has been shown that most of those roused T cell armies are helper CD4+ T ce ...
Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health’s Clinical Center in Bethesda, Maryland. Researchers at the National Institute of Allergy and Infectious Diseases (NIAID) are conduct ...
British scientists say a former nurse has become the first person in the country to receive an experimental Ebola vaccine in an early trial to test its safety. Ruth Atkins, 48, got the injection on Wednesday in Oxford, the first of 60 healthy volunt ...
Johnson & Johnson announced it will fast-track the development of a promising new combination vaccine regimen against Ebola and broadly collaborate with its partners in global health to deliver immediate relief aid to address the current Ebola ou ...
This Aug. 12, 2014 file photo shows a healthcare worker walking near an Ebola isolation unit, part of the Ebola outbreak response, wearing protective gear against the virus at Kenema Government Hospital in Kenema, Sierra Leone. Federal researchers ne ...
Director General of the World Health Organization, WHO, China's Margaret Chan and Assistant Director General for Health Security Keiji Fukuda of the US, right, share a word during a press conference after an emergency meeting at the headquarters of t ...
Charlie Arntzen has worked tirelessly on new platforms to deliver drugs. He has focused on plant-based drug delivery systems, testing a wide range of plants as possible “manufacturing platforms” for therapeutics for the developing world. Now Arntz ...